Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 48K
2: EX-99.1 Miscellaneous Exhibit HTML 814K
3: EX-99.2 Miscellaneous Exhibit HTML 4.86M
4: EX-99.3 Miscellaneous Exhibit HTML 41K
9: R1 Document and Entity Information Document HTML 57K
12: XML IDEA XML File -- Filing Summary XML 13K
10: XML XBRL Instance -- met-20220803_htm XML 34K
11: EXCEL IDEA Workbook of Financial Reports XLSX 8K
6: EX-101.DEF XBRL Definitions -- met-20220803_def XML 43K
7: EX-101.LAB XBRL Labels -- met-20220803_lab XML 88K
8: EX-101.PRE XBRL Presentations -- met-20220803_pre XML 43K
5: EX-101.SCH XBRL Schema -- met-20220803 XSD 11K
13: JSON XBRL Instance as JSON Data -- MetaLinks 14± 21K
14: ZIP XBRL Zipped Folder -- 0001099219-22-000112-xbrl Zip 263K
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name
or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i☐
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon Stock, par value $0.01
iMET
iNew
York Stock Exchange
iFloating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01
iMET PRA
iNew
York Stock Exchange
iDepositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E
iMET PRE
iNew
York Stock Exchange
iDepositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F
iMET PRF
iNew
York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☐
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On August 3, 2022, MetLife, Inc. issued (i) a news release announcing its results for the quarter ended June 30, 2022 (the “Earnings Release”),
a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, and (ii) a Quarterly Financial Supplement for the quarter ended June 30, 2022 (the “Quarterly Financial Supplement”), a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference. The Earnings Release and the Quarterly Financial Supplement are furnished and not filed pursuant to instruction B.2 of Form 8-K.
Item 7.01 Regulation FD Disclosure.
On
August 3, 2022, MetLife, Inc. issued a supplemental slide presentation for the quarter ended June 30, 2022 (the “Supplemental Slides”), a copy of which is attached hereto as Exhibit 99.3 and is incorporated herein by reference. The slides highlight information in MetLife, Inc.’s Earnings Release and Quarterly Financial Supplement. The Supplemental Slides are furnished and not filed pursuant to instruction B.2 of Form 8-K.
Pursuant to Rule 406 of Regulation S-T, the
cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language)
104
Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.